Evidence suggests that decreased expression of GSTP1 or CYP1A1 induced by polymorphisms at their respective gene loci has been associated with many liver diseases such as hepatocellular carcinoma [7–10]. This evidence concerns the gene GSTP1 and hepatocellular carcinoma.